ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
EOM Pharmaceuticals, Inc. and Immunocellular Therapeutics, Ltd. Announce Entry into and Close of Definitive Merger Agreement
December 06, 2021EOM Pharmaceuticals, Inc., a privately held, clinical-stage pharmaceutical company, and ImmunoCellular Therapeutics, Ltd. announced that the companies have entered into and closed on a merger agreement pursuant to which the shareholders of EOM are now... -
EOM Pharmaceuticals Announces First Patients Dosed In R1: RESCUE Phase 1/2a Open-label Trial Evaluating EOM613 In Hospitalized COVID-19 Patients With Severe Symptoms In Brazil
August 25, 2021EOM announced the first patients have been dosed in R1: RESCUE, a proof-of-concept Phase 1/2a open-label multicenter clinical study in Brazil to evaluate safety, tolerability, and preliminary efficacy of EOM613 in hospitalized COVID-19 infected patients
Pharma Sources Insight January 2025
